Free Trial
→ Iran's New Leader Just Said Something That Should Terrify Every American (From American Alternative) (Ad)tc pixel Free CWEB Stock Alerts

Charlotte's Web (CWEB) Competitors

Charlotte's Web logo
C$0.65 -0.08 (-10.96%)
As of 03:59 PM Eastern
Compare

CWEB vs. CPH, ACB, SUGR, OGI, and FIRE

Should you be buying Charlotte's Web stock or one of its competitors? The main competitors of Charlotte's Web include Cipher Pharmaceuticals (CPH), Aurora Cannabis (ACB), SugarBud Craft Growers (SUGR), Organigram (OGI), and Supreme Cannabis (FIRE). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does Charlotte's Web compare to Cipher Pharmaceuticals?

Cipher Pharmaceuticals (TSE:CPH) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.

Cipher Pharmaceuticals has a beta of 0.725282, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, Charlotte's Web has a beta of 1.63578, suggesting that its share price is 64% more volatile than the S&P 500.

2.3% of Cipher Pharmaceuticals shares are held by institutional investors. Comparatively, 2.6% of Charlotte's Web shares are held by institutional investors. 42.0% of Cipher Pharmaceuticals shares are held by company insiders. Comparatively, 11.3% of Charlotte's Web shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cipher Pharmaceuticals has a net margin of 54.37% compared to Charlotte's Web's net margin of -59.60%. Cipher Pharmaceuticals' return on equity of 24.23% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Cipher Pharmaceuticals54.37% 24.23% 7.90%
Charlotte's Web -59.60%-275.39%-17.25%

Cipher Pharmaceuticals has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cipher PharmaceuticalsC$50.45M9.07C$11.41MC$1.0517.25
Charlotte's WebC$49.90M2.09-C$25.55M-C$0.19N/A

In the previous week, Cipher Pharmaceuticals and Cipher Pharmaceuticals both had 2 articles in the media. Charlotte's Web's average media sentiment score of 0.68 beat Cipher Pharmaceuticals' score of 0.00 indicating that Charlotte's Web is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cipher Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Charlotte's Web
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Cipher Pharmaceuticals beats Charlotte's Web on 9 of the 12 factors compared between the two stocks.

How does Charlotte's Web compare to Aurora Cannabis?

Aurora Cannabis (TSE:ACB) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk.

Aurora Cannabis currently has a consensus price target of C$9.25, indicating a potential upside of 96.81%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, equities analysts clearly believe Aurora Cannabis is more favorable than Charlotte's Web.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Charlotte's Web
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Aurora Cannabis has a beta of 0.40301, meaning that its stock price is 60% less volatile than the S&P 500. Comparatively, Charlotte's Web has a beta of 1.63578, meaning that its stock price is 64% more volatile than the S&P 500.

Aurora Cannabis has a net margin of -1.69% compared to Charlotte's Web's net margin of -59.60%. Aurora Cannabis' return on equity of -1.15% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-1.69% -1.15% -1.87%
Charlotte's Web -59.60%-275.39%-17.25%

In the previous week, Charlotte's Web had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 2 mentions for Charlotte's Web and 1 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.90 beat Charlotte's Web's score of 0.68 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Charlotte's Web
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

4.2% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 2.6% of Charlotte's Web shares are owned by institutional investors. 11.3% of Charlotte's Web shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Charlotte's Web has lower revenue, but higher earnings than Aurora Cannabis. Charlotte's Web is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$373.12M0.74-C$44.16M-C$1.50N/A
Charlotte's WebC$49.90M2.09-C$25.55M-C$0.19N/A

Summary

Aurora Cannabis beats Charlotte's Web on 10 of the 16 factors compared between the two stocks.

How does Charlotte's Web compare to SugarBud Craft Growers?

Charlotte's Web (TSE:CWEB) and SugarBud Craft Growers (CVE:SUGR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

Charlotte's Web has a beta of 1.63578, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, SugarBud Craft Growers has a beta of 2.768948, suggesting that its share price is 177% more volatile than the S&P 500.

2.6% of Charlotte's Web shares are held by institutional investors. Comparatively, 0.4% of SugarBud Craft Growers shares are held by institutional investors. 11.3% of Charlotte's Web shares are held by insiders. Comparatively, 30.2% of SugarBud Craft Growers shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

SugarBud Craft Growers has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than SugarBud Craft Growers, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charlotte's WebC$49.90M2.09-C$25.55M-C$0.19N/A
SugarBud Craft GrowersC$668.94M0.41C$12.12MC$1.686.83

SugarBud Craft Growers has a net margin of 2.11% compared to Charlotte's Web's net margin of -59.60%. SugarBud Craft Growers' return on equity of 10.07% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Charlotte's Web-59.60% -275.39% -17.25%
SugarBud Craft Growers 2.11%10.07%5.13%

In the previous week, Charlotte's Web had 2 more articles in the media than SugarBud Craft Growers. MarketBeat recorded 2 mentions for Charlotte's Web and 0 mentions for SugarBud Craft Growers. Charlotte's Web's average media sentiment score of 0.68 beat SugarBud Craft Growers' score of 0.00 indicating that Charlotte's Web is being referred to more favorably in the media.

Company Overall Sentiment
Charlotte's Web Positive
SugarBud Craft Growers Neutral

Summary

SugarBud Craft Growers beats Charlotte's Web on 9 of the 13 factors compared between the two stocks.

How does Charlotte's Web compare to Organigram?

Charlotte's Web (TSE:CWEB) and Organigram (TSE:OGI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, risk and valuation.

In the previous week, Charlotte's Web had 2 more articles in the media than Organigram. MarketBeat recorded 2 mentions for Charlotte's Web and 0 mentions for Organigram. Charlotte's Web's average media sentiment score of 0.68 beat Organigram's score of 0.00 indicating that Charlotte's Web is being referred to more favorably in the media.

Company Overall Sentiment
Charlotte's Web Positive
Organigram Neutral

Charlotte's Web has a beta of 1.63578, meaning that its share price is 64% more volatile than the S&P 500. Comparatively, Organigram has a beta of 1.535528, meaning that its share price is 54% more volatile than the S&P 500.

Charlotte's Web has higher earnings, but lower revenue than Organigram. Charlotte's Web is trading at a lower price-to-earnings ratio than Organigram, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charlotte's WebC$49.90M2.09-C$25.55M-C$0.19N/A
OrganigramC$279.99M0.95-C$57.23MC$0.1512.27

2.6% of Charlotte's Web shares are held by institutional investors. Comparatively, 4.0% of Organigram shares are held by institutional investors. 11.3% of Charlotte's Web shares are held by insiders. Comparatively, 31.3% of Organigram shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Organigram has a consensus price target of C$3.13, indicating a potential upside of 65.34%. Given Organigram's stronger consensus rating and higher possible upside, analysts clearly believe Organigram is more favorable than Charlotte's Web.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charlotte's Web
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Organigram
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Organigram has a net margin of 6.49% compared to Charlotte's Web's net margin of -59.60%. Organigram's return on equity of 4.86% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Charlotte's Web-59.60% -275.39% -17.25%
Organigram 6.49%4.86%-5.56%

Summary

Organigram beats Charlotte's Web on 11 of the 16 factors compared between the two stocks.

How does Charlotte's Web compare to Supreme Cannabis?

Supreme Cannabis (TSE:FIRE) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability and valuation.

Supreme Cannabis has a net margin of 0.00% compared to Charlotte's Web's net margin of -59.60%. Supreme Cannabis' return on equity of 0.00% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Supreme CannabisN/A N/A N/A
Charlotte's Web -59.60%-275.39%-17.25%

In the previous week, Charlotte's Web had 2 more articles in the media than Supreme Cannabis. MarketBeat recorded 2 mentions for Charlotte's Web and 0 mentions for Supreme Cannabis. Charlotte's Web's average media sentiment score of 0.68 beat Supreme Cannabis' score of 0.00 indicating that Charlotte's Web is being referred to more favorably in the news media.

Company Overall Sentiment
Supreme Cannabis Neutral
Charlotte's Web Positive

Supreme Cannabis has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than Supreme Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Supreme CannabisC$53.29M0.00-C$23.65M-C$0.03N/A
Charlotte's WebC$49.90M2.09-C$25.55M-C$0.19N/A

2.6% of Charlotte's Web shares are owned by institutional investors. 11.3% of Charlotte's Web shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Supreme Cannabis beats Charlotte's Web on 6 of the 11 factors compared between the two stocks.

Get Charlotte's Web News Delivered to You Automatically

Sign up to receive the latest news and ratings for CWEB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CWEB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CWEB vs. The Competition

Export
MetricCharlotte's WebDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$104.35MC$1.63BC$6.24BC$11.72B
Dividend YieldN/A2.97%2.73%6.22%
P/E Ratio-3.424.1829.0423.83
Price / Sales2.091,488.53477.1013.46
Price / Cash8.9010.3727.6282.69
Price / Book-50.5610.729.674.48
Net Income-C$25.55MC$21.15BC$3.55BC$300.68M
7 Day Performance-19.75%-1.16%1.70%0.12%
1 Month Performance-36.27%0.17%5.62%2.88%
1 Year Performance441.67%24.19%34.42%57.78%

Charlotte's Web Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CWEB
Charlotte's Web
N/AC$0.65
-11.0%		N/AN/AC$104.35MC$49.90MN/A164
CPH
Cipher Pharmaceuticals
N/AC$17.71
-2.2%		N/AN/AC$447.73MC$50.45M16.875
ACB
Aurora Cannabis
2.0225 of 5 stars		C$4.67
+3.5%		C$9.25
+98.1%		N/AC$276.12MC$373.12MN/A1,073
SUGR
SugarBud Craft Growers
N/AC$11.47
flat		N/AN/AC$276.07MC$668.94M6.8344
OGI
Organigram
3.5773 of 5 stars		C$1.91
+2.7%		C$3.13
+63.6%		N/AC$268.62MC$279.99M12.40987

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:CWEB) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel